Report Detail
Global Pimozide Market Growth 2019-2024
- RnM3065138 |
- 06 March, 2019 |
- Global |
- 130 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global average price of Pimozide is in the increasing trend, from 1.13 USD/Unit in 2013 to 1.19 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Pimozide includes 1Mg, 2Mg, 4Mg, and the proportion of 2Mg in 2017 is about 53%.
Pimozide is widely used in hospitals, drugstores and other places. The most proportion of Pimozide is used for hospitals in 2017 is 54%.
According to this study, over the next five years the Pimozide market will register a -1.1% CAGR in terms of revenue, the global market size will reach US$ 11 million by 2024, from US$ 12 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pimozide business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pimozide market by product type, application, key manufacturers and key regions and countries.
This study considers the Pimozide value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
1Mg
2Mg
4Mg
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Drugstores
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pimozide consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pimozide market by identifying its various subsegments.
Focuses on the key global Pimozide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pimozide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pimozide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Pimozide Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pimozide Consumption 2014-2024
- 2.1.2 Pimozide Consumption CAGR by Region
- 2.2 Pimozide Segment by Type
- 2.2.1 1Mg
- 2.2.2 2Mg
- 2.2.3 4Mg
- 2.3 Pimozide Consumption by Type
- 2.3.1 Global Pimozide Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Pimozide Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Pimozide Sale Price by Type (2014-2019)
- 2.4 Pimozide Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Drugstores
- 2.4.3 Others
- 2.5 Pimozide Consumption by Application
- 2.5.1 Global Pimozide Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Pimozide Value and Market Share by Application (2014-2019)
- 2.5.3 Global Pimozide Sale Price by Application (2014-2019)
3 Global Pimozide by Players
- 3.1 Global Pimozide Sales Market Share by Players
- 3.1.1 Global Pimozide Sales by Players (2017-2019)
- 3.1.2 Global Pimozide Sales Market Share by Players (2017-2019)
- 3.2 Global Pimozide Revenue Market Share by Players
- 3.2.1 Global Pimozide Revenue by Players (2017-2019)
- 3.2.2 Global Pimozide Revenue Market Share by Players (2017-2019)
- 3.3 Global Pimozide Sale Price by Players
- 3.4 Global Pimozide Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Pimozide Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Pimozide Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Pimozide by Regions
- 4.1 Pimozide by Regions
- 4.1.1 Global Pimozide Consumption by Regions
- 4.1.2 Global Pimozide Value by Regions
- 4.2 Americas Pimozide Consumption Growth
- 4.3 APAC Pimozide Consumption Growth
- 4.4 Europe Pimozide Consumption Growth
- 4.5 Middle East & Africa Pimozide Consumption Growth
5 Americas
- 5.1 Americas Pimozide Consumption by Countries
- 5.1.1 Americas Pimozide Consumption by Countries (2014-2019)
- 5.1.2 Americas Pimozide Value by Countries (2014-2019)
- 5.2 Americas Pimozide Consumption by Type
- 5.3 Americas Pimozide Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Pimozide Consumption by Countries
- 6.1.1 APAC Pimozide Consumption by Countries (2014-2019)
- 6.1.2 APAC Pimozide Value by Countries (2014-2019)
- 6.2 APAC Pimozide Consumption by Type
- 6.3 APAC Pimozide Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Pimozide by Countries
- 7.1.1 Europe Pimozide Consumption by Countries (2014-2019)
- 7.1.2 Europe Pimozide Value by Countries (2014-2019)
- 7.2 Europe Pimozide Consumption by Type
- 7.3 Europe Pimozide Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Pimozide by Countries
- 8.1.1 Middle East & Africa Pimozide Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Pimozide Value by Countries (2014-2019)
- 8.2 Middle East & Africa Pimozide Consumption by Type
- 8.3 Middle East & Africa Pimozide Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Pimozide Distributors
- 10.3 Pimozide Customer
11 Global Pimozide Market Forecast
- 11.1 Global Pimozide Consumption Forecast (2019-2024)
- 11.2 Global Pimozide Forecast by Regions
- 11.2.1 Global Pimozide Forecast by Regions (2019-2024)
- 11.2.2 Global Pimozide Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Pimozide Forecast by Type
- 11.8 Global Pimozide Forecast by Application
12 Key Players Analysis
- 12.1 Teva
- 12.1.1 Company Details
- 12.1.2 Pimozide Product Offered
- 12.1.3 Teva Pimozide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Teva News
- 12.2 Par Pharmaceutical
- 12.2.1 Company Details
- 12.2.2 Pimozide Product Offered
- 12.2.3 Par Pharmaceutical Pimozide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Par Pharmaceutical News
- 12.3 Johnson & Johnson
- 12.3.1 Company Details
- 12.3.2 Pimozide Product Offered
- 12.3.3 Johnson & Johnson Pimozide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Johnson & Johnson News
- 12.4 Eumedica
- 12.4.1 Company Details
- 12.4.2 Pimozide Product Offered
- 12.4.3 Eumedica Pimozide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Eumedica News
- 12.5 Pharmascience
- 12.5.1 Company Details
- 12.5.2 Pimozide Product Offered
- 12.5.3 Pharmascience Pimozide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Pharmascience News
- 12.6 Domina Pharmaceuticals
- 12.6.1 Company Details
- 12.6.2 Pimozide Product Offered
- 12.6.3 Domina Pharmaceuticals Pimozide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Domina Pharmaceuticals News
- 12.7 Aa Pharma
- 12.7.1 Company Details
- 12.7.2 Pimozide Product Offered
- 12.7.3 Aa Pharma Pimozide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Aa Pharma News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pimozide . Industry analysis & Market Report on Pimozide is a syndicated market report, published as Global Pimozide Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Pimozide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
